Flowable Hemostats Market Report 2026

Flowable Hemostats Market Overview

• Flowable Hemostats market size has reached to $1.02 billion in 2025 • Expected to grow to $1.47 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Rising Surgical Procedures Drive Growth In Flowable Hemostats Market • Market Trend: Advanced Flowable Hemostatic Gel Enhances Surgical Bleeding Control • North America was the largest region in 2025.

What Is Covered Under Flowable Hemostats Market?

Flowable hemostats are gelatinous medical devices used to control bleeding during surgery, conforming to irregular wound shapes for effective application. They promote clotting by forming a physical barrier and activating the body's coagulation cascade, making them ideal for complex or delicate surgical areas. The main types of products in flowable hemostats are active hemostats, passive hemostats, and combination hemostats. Active hemostats refers to specialized medical agents that actively participate in the blood clotting process, enhancing hemostasis during surgical procedures or in cases of bleeding. These hemostats can be composed of different materials, such as porcine gelatin and bovine gelatin, and are utilized across various surgical applications, including general surgery, cardiac surgery, vascular surgery, neuro and spine surgery, orthopedic surgery, and more. They are designed to meet the needs of various end users, including hospitals and clinics, as well as ambulatory surgery centers.

What Is The Flowable Hemostats Market Growth Forecast?

The flowable hemostats market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing demand for faster bleeding control, rising focus on patient safety outcomes, expansion of minimally invasive and robotic surgeries, growing innovation in bioresorbable materials, increasing use in emergency and trauma care. Major trends in the forecast period include increasing use of flowable hemostats in complex surgeries, rising adoption of combination hemostatic products, growing demand for rapid hemostasis solutions, expansion of minimally invasive surgical applications, enhanced focus on biocompatible materials.

Global Flowable Hemostats Market Segmentation

1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats 2) By Material: Porcine Gelatin, Bovine Gelatin 3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications 4) By End User: Hospital And Clinics, Ambulatory Surgery Centers Subsegments: 1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats 2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats 3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats

What Is The Driver Of The Flowable Hemostats Market?

An increasing number of surgical procedures is expected to propel the growth of the flowable hemostats market going forward. The number of surgical procedures is increasing due to an aging population, which drives demand for age-related surgeries, and technological advancements that have made surgeries safer and more accessible. Flowable hemostats are highly useful in surgical procedures as it helps in control bleeding in areas that are difficult to access or where traditional methods may not be effective. For instance, in June 2024, according to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, in 2023, the total number of surgical and non-surgical procedures rose by 3.4%, reaching 34.9 million, compared to the previous year. Therefore, the increasing number of surgical procedures is driving the growth of the flowable hemostats industry.

Key Players In The Global Flowable Hemostats Market

Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

Global Flowable Hemostats Market Trends and Insights

Major companies operating in the flowable hemostats market are focusing on developing surgically advanced hemostatic agents, such as no-swell technology, to address the evolving needs of surgical procedures. No-swell technology refers to a property of a hemostatic agent that prevents it from absorbing fluids and expanding, making it suitable for use in surgeries where swelling could cause complications. For instance, in January 2023, Medcura Inc., a US-based surgical technology platform, received Food and Drug Administration (FDA) breakthrough device designation for its LifeGel flowable technology that controls bleeding during surgery for procedures where swelling cannot be tolerated. Medcura's LifeGel is the first and only flowable hemostatic gel designed to address challenges specific to hemostatic swelling. The absorbable agent does not swell as it is fully hydrated and ready-to-use, potentially mitigating risks associated with swelling, such as nerve injury and paralysis. It is cost-effective, retains antimicrobial properties, relatively transparent, and mucoadheres to tissues, offering a safer and more effective solution for controlling bleeding during complex surgical procedures.

What Are Latest Mergers And Acquisitions In The Flowable Hemostats Market?

In May 2025, Merit Medical Systems Inc, a US-based manufacturer of medical devices used in interventional, diagnostic and therapeutic procedures, acquired Biolife Delaware LLC for approximately US 120 million. Through this acquisition, Merit gains access to Biolife’s proprietary hemostatic product portfolio including StatSeal and WoundSeal, which strengthens Merits procedural hemostasis capabilities and supports the delivery of standardized and reliable bleeding control solutions for vascular access and post procedure care. Biolife Delaware is a US-based medical device company that develops hemostatic products in powder and disc formats designed to rapidly seal bleeding at catheter and procedural access sites.

Regional Outlook

North America was the largest region in the flowable hemostats market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Flowable Hemostats Market?

The flowable hemostats market consists of sales of synthetic flowable hemostats, fibrin sealant-based hemostats, and collagen-based flowable hemostats. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Flowable Hemostats Market Report 2026?

The flowable hemostats market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the flowable hemostats industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.